The quality of Cardiovascular medicines

Today, there is a growing need for good quality cardiovascular medicines and devices for the prevention and management of the ever-growing threats of cardiovascular diseases(CVDs) globally. That is why the objective of this study was to review the available literature on SF cardiovascular medicines/devices, with a focus on prevalence studies to discuss their impacts on ...

The 21st edition of the International Pharmaceutical Forum

The 21st edition of the International Pharmaceutical Forum scheduled from 13 to 16 October 2021 was announced by the Order of Pharmacists of Côte d’Ivoire. The announcement was made during a press conference at the headquarters of the organization, Wednesday, September 8, 2021, in Abidjan Cocody. The President of the National Council of the Order ...

JOB OFFER: Software Engineer and Data Scientist

The Medicine Quality Research Group is looking for a Software Engineer and Data Scientist, to join the planning and execution of software development projects at the Centre for Tropical Medicine and Global Health. The Software Engineer and Data Scientist will be a key member of the Medicine Quality Research Group to lead and coordinate the ...

JOB VACANCY: Strategic Advisor, Pharmaceutical and Vaccine Manufacturing at Tony Blair Institute

The specific duties include: Conducting relevant analysis as needed to progress the delivery of the pharmaceutical and vaccine manufacturing agenda, supporting the development and implementation of bankable projects for investors in the vaccine production and pharmaceutical sector linking with other key Government institutions with a stake in this agenda, working with the Government counterparts at ...

RAFAELLA’S LITERATURE UPDATE

Be-cause Health & QUAMED literature updates Ref: World Health Organization. Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin. WHO 2021. ISBN 978-92-4-002213-3 (electronic version). Dear Friends, Today, I would like to share a WHO regulatory document concerning the quality of oxytocin-containing products. You can download it at this link: https://www.who.int/publications/i/item/9789240022133 ...

Webinar: Technological innovations for pharmacy in Africa amidst the Covid-19 pandemic

Dr. Prosper Hiag, who facilitated our last QUAMED member webinar, appealed to drug regulators in Africa at a regional workshop in Lagos, Nigeria. He asked them to enact laws to guide the practice of internet pharmacy across the continent. The event was held under the theme: “Technological innovations for pharmacy in Africa amidst the Covid-19 ...

The importance of Pharmacovigilance:

The collection and assessment of adverse reactions are important in the first decade after the marketing authorization of a drug. The information gathered in this period could help, for example, identify complications from its use that were unknown before its commercialization. However, when it comes to medicines that have been on the market for a ...

Rafaella’s Literature Update

Be-cause Health & QUAMED literature updates Ref (1): US Pharmacopoeia, Increasing Transparency in the Medicines Supply Chain, 2021 Ref (2): US Pharmacopoeia, Global Public Policy Position: Key Elements to Building a More Resilient Supply Chain Dear Friend, The more diffuse and fragmented the supply chain is, the greater the risk that important information about the origin, production ...

Recent resources for biologics utilized in COVID-19 treatments and vaccines available on USP website

USP has developed interesting material on quality and Covid-19. They include an infographic on production standards of Covid-19 vaccines and standards for quality assessment of COVID-19 vaccines. Follow these links for more information: Ensuring quality in monoclonal antibody development and COVID-19 Vaccine Quality Attributes Toolkits. Another great USP resource is the COVID-19 Vaccine Handling Guides. They have recently been ...

PIC/S: COVID-19 Risk Assessment for Routine On-Site Inspections

 It is interesting to see that PIC/S has adopted guidance on “COVID-19 Risk Assessment for Routine On-Site Inspections” (PI 055-1). It entered into force on 15 July 2021. Please follow the following link to the PIC/S website “Publications” https://picscheme.org/en/news to download this document. It was nice to see that the larger suppliers that we have audited ...